| Drug Development |
|
ReceptoPharm is developing proprietary
therapeutic protein products for the treatment of neurological,
viral and and autoimmune disorders. |
| »
Learn More |
|
|
| |
|
ReceptoPharm is a wholly-owned subsidiary of Nutra Pharma Corporation.ReceptoPharm is an innovative biopharmaceutical
drug discovery company developing proprietary
therapeutic protein products primarily for
the prevention and treatment of viral, autoimmune
and neurological diseases in humans, including
Adrenomyeloneuropathy (AMN), Multiple Sclerosis
(MS), Rheumatoid Arthritis (RA), Pain, and
Myasthenia Gravis (MG), and Human Immunodeficiency
Virus (HIV).
The emphasis of ReceptoPharm's approach
to drug discovery and the development of
new therapeutic agents is based upon specialized
receptor-binding proteins found in nature.
» Learn
More
|
| E-Alerts
|
| Signup to receive news and announcements
from ReceptoPharm and Nutra Pharma: |
|
|
|
|
|
|
|
